Abbott Labs to Market Gensia Sicor Products
Gensia Sicor Inc. said its Gensia Sicor Pharmaceuticals Inc. subsidiary has signed a long-term agreement for Abbott Laboratories to handle the marketing and distribution of Gensia Sicor’s portfolio of oncology products throughout the United States.
Financial terms were not disclosed.
Irvine-based Gensia Sicor develops and markets pharmaceuticals and has operations in the United States, Italy and Mexico. The company’s stock closed Friday at $5.31, up 13 cents.
More to Read
-
Baby formula maker says agreement reached to reopen plant
-
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
